ClarityDX Prostate: A New Way to Detect Prostate Cancer
On November 1, 2023, CEO John Lewis presented a webinar for Prostate Cancer Foundation Canada called “ClarityDX Prostate: A New Way to Detect Prostate Cancer.” Click on the Webinar button below to watch it! Go to PCFC’s website here to check out the rest of their video library.
ClarityDX Prostate is an innovative blood test that marks a significant advancement in prostate cancer screening. It provides critical support to men, aged 40 to 75, and their physicians in making more informed decisions, with 3X the accuracy, about whether a biopsy is required following a high prostate-specific antigen (PSA) test result.
